EP2124997
Notkun á IL-1 mótlyfjum til að meðhöndla þvagsýrugigt og brjóskkölkun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
19.10.2007EP published:
8.8.2012EP application number:
07839723.9
EP translation filed:
1.10.2012Grant published:
15.10.2012EPO information:
European Patent Register
Max expiry date:
18.10.2027Expiry date:
18.10.2021
Title:
USE OF IL-1 ANTAGONISTS TO TREAT GOUT AND PSEUDOGOUT
Timeline
Today
19.10.2007EP application
8.8.2012EP Publication
1.10.2012Translation submitted
15.10.2012Registration published
18.10.2021Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill Road, 10591, Tarrytown, NY, US
Inventor
Name:
VICARY, CatherineAddress:
New York, NY, US
Name:
MELLIS, ScottAddress:
New Rochelle, NY, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
853385 PDate:
20.10.2006Country:
US
Classification
Categories:
A61K 38/17, A61K 38/20, A61P 19/06, A61P 19/02
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 21.12.2012
Expires: 18.10.2013
Payer: Árnason Faktor
Number: 7
Paid: 4.10.2013
Expires: 18.10.2014
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 1.10.2014
Expires: 18.10.2015
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 6.10.2015
Expires: 18.10.2016
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 10
Paid: 21.9.2016
Expires: 18.10.2017
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 11
Paid: 22.9.2017
Expires: 18.10.2018
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 12
Paid: 19.9.2018
Expires: 18.10.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 13
Paid: 18.9.2019
Expires: 18.10.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 14
Paid: 17.9.2020
Expires: 18.10.2021
Payer: Patice ehf.